AC Immune SA Announces 2025 AGM Details and Board Changes
Ticker: ACIU · Form: 6-K · Filed: May 19, 2025 · CIK: 1651625
| Field | Detail |
|---|---|
| Company | Ac Immune SA (ACIU) |
| Form Type | 6-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, board-of-directors, corporate-governance
TL;DR
AC Immune's AGM is June 19th, with board member changes on the table.
AI Summary
AC Immune SA announced its 2025 Annual General Meeting (AGM) invitation and proxy card on May 19, 2025, for the meeting scheduled on June 19, 2025. The company also disclosed that certain board members will not be standing for re-election, with new candidates proposed for election at the upcoming AGM.
Why It Matters
This filing provides shareholders with crucial information regarding the upcoming Annual General Meeting, including proposed board changes, which can impact corporate governance and strategic direction.
Risk Assessment
Risk Level: low — The filing is procedural, announcing an upcoming meeting and related materials, with no immediate financial or operational risks disclosed.
Key Players & Entities
- AC Immune SA (company) — Registrant
- May 19, 2025 (date) — Date of AGM Invitation publication
- June 19, 2025 (date) — Date of 2025 AGM
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing is to report the publication of AC Immune SA's Annual General Meeting (AGM) Invitation and General Meeting Proxy Card for the 2025 AGM.
When is the 2025 Annual General Meeting of AC Immune SA scheduled to take place?
The 2025 Annual General Meeting is scheduled to be held on June 19, 2025.
What key documents are being provided with this filing?
Exhibits 99.1, 99.2, and 99.3, which are copies of the AGM Invitation and General Meeting Proxy Cards, are attached to this Report on Form 6-K.
Are there any changes to the Board of Directors mentioned?
Yes, the filing indicates that certain board members will not be standing for re-election, and new proposed board members will be presented at the AGM.
What is the company's principal executive office address?
The principal executive offices are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 19, 2025 regarding AC Immune SA (ACIU).